BEUDAMED
    FDA PMA FDA Class 3 30-Day Notice Accepted 🇺🇸 United States

    Kit, Dna Detection, Human Papillomavirus

    PMA: P080014 · Supplement: S010 · Decision Jan 20, 2012
    View on FDA
    Classifications
    1
    FEI Numbers
    12
    Registration Numbers
    12

    Basic Information

    Device Name
    Kit, Dna Detection, Human Papillomavirus
    Trade Name
    CERVISTA HUMAN PAPILLOMA VIRUS (HPV) HIGH RISK (HR)
    PMA Number
    P080014
    Supplement Number
    S010
    Device Class
    FDA Class 3
    Product Code
    MAQ
    Generic Name
    KIT, DNA DETECTION, HUMAN PAPILLOMAVIRUS
    Medical Specialty
    Unknown
    Advisory Committee
    Microbiology
    Decision
    30-Day Notice Accepted
    Decision Code
    OK30
    Decision Date
    January 20, 2012
    Date Received
    December 28, 2011
    Supplement Type
    30-Day Notice
    Supplement Reason
    Process Change - Manufacturer/Sterilizer/Packager/Supplier
    Expedited Review
    N

    Advisory Committee Statement

    CHANGE TO REPLACE QUALITY CONTROL TEST METHOD CONTROLS WITH NEW QUALITY CONTROL TEST METHOD CONTROLS FROM THE SAME SUPPLIER FOR INCOMING MATERIALS INSPECTION TESTING AND IN-PROCESS QUALITY CONTROL TESTING OF ACCESSORY KIT REAGENTS.

    Classifications

    This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

    Product Code Device Name
    MAQ Kit, Dna Detection, Human Papillomavirus